【主編教材】
1.《藥物化學(xué)》（十一五國家級(jí)規(guī)劃教材） 中國高等教育出版社 主編 2006年
2.《藥物設(shè)計(jì)學(xué)》（十一五國家級(jí)規(guī)劃教材） 人民衛(wèi)生出版社 主編 2007年
3.《藥物化學(xué)》 （衛(wèi)生部規(guī)劃教材） 人民衛(wèi)生出版社 主編 2000年
4.《新藥設(shè)計(jì)與開發(fā)》 科學(xué)出版社 主編 2001年
5.《新藥設(shè)計(jì)原理與方法》 中國醫(yī)藥科技出版社 主編 1997年
6.《國家執(zhí)業(yè)藥師資格考試全書》 北京科技出版社 主編 2003年
【申請專利】
1.《吡咯烷類基質(zhì)金屬蛋白酶抑制劑及其制備方法》（No：ZL 200310105422.7）2006年
2.《川芎醇酯類衍生物及其制備方法和含有川芎醇酯類衍生物的藥物組合物與應(yīng)用》(專利號(hào)：ZL 1424313A）2005年
3.《環(huán)酰亞胺類肽金屬蛋白酶抑制劑及其應(yīng)用》(專利申請?zhí)枺?00610146207.5）2006年
4.《一種含N3-鄰甲苯甲?；蜞奏?nbsp;(TFU) 的藥物組合物及其脂質(zhì)體制劑》(專利申請?zhí)枺篘o：200610042246.0）2006年
【代表性學(xué)術(shù)論文】（近三年）
1. Xian-Chao Cheng, Qiang Wang, Hao Fang and Wen-Fang Xu*. Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold. Current Medicinal Chemistry, 2008, 15 (4), 374-385.
2. Xian-Chao Cheng, Qiang Wang, Hao Fang and Wen-Fang Xu*. Role of sulfonamide group in matrix metalloproteinase inhibitors. Current Medicinal Chemistry, 2008, 15 (4), 368-373.
3. Xian-Chao Cheng, Qiang Wang, Hao Fang, Zi-Yao Tang, Wen-Fang Xu*. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors. Eur J Med Chem，2008, 1-10.
4. Xian-Chao Cheng, Hao Fang and Wen-Fang Xu*. Advances in assays of matrix metalloproteinases (MMPs) and their Inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 2008, 23 (2), 154-167.
5. Xian-Chao Cheng, Qiang Wang, Hao Fang, Wei Tang, Wen-Fang Xu*. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors. Bioorg Med Chem, 2008, 16(10), 5398-5404.
6. Jie Zhang, Wenfang Xu*, Guanhua Du. Synthesis, inhibitory activity and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors. Bioorg Med Chem, 2008, 16(9), 3839-3847.
7. Jie Zhang, Wenfang Xu*, Ailin Liu, Guanhua Du, Design, synthesis, preliminary evaluation of new pyrrolidine derivatives as neuraminidase inhibitors. Med Chem, 2008, 4(3), 206~209.
8. Qiang wang, Maoying chen, Huawei zhu, Jie zhang, Hao fang, Binghe wang, Wenfang Xu*.Design Synthesis and QSAR Studies of Novel Lysine Derives as Aminopeptidase N/CD13 Inhibitors. Bioorg Med Chem. 2008, 16(10), 5473-5481.
9. Liu FZ, Fang H, Zhu HW, Wang Q, Yang Y, Xu WF*. Design, synthesis, and preliminary evaluation of 4-(6-(3-nitroguanidino)hexanamido)pyrrolidine derivatives as potential iNOS inhibitors. Bioorg Med Chem. 2008, 16(1), 578-585.
10. Huawei zhu, Hao fang, Luyao wang, Wenxiang hu, Wenfang Xu*. 3D-QSAR Study with Pharmacophore-based Molecular Alignment of Hydroxamic acid-related Phosphinates that are Aminopeptidase N Inhibitors, Drug Discov Ther 2008; 2(1), 52-57.
11. Yepeng Luan, jiajia Mu and Wenfang Xu*, The Review of the Synthesis of Bestatin an Effective Inhibitor of Aminopeptidase N, Mini-Rev Org Chem 2008, 5, 134-140.
12. Yingjie Zhang and Wenfang Xu*, Progress on Kinesin Spindle Protein Inhibitors as Anticancer Agents, Anti-cancer Agents Med. Chem, 2008, 8.
13. Luqing Shang, Takehiko meala Wenfang Xu and Shiroki Kishioka, Evaluation of a novel aminopeptidase N inhibitor, in vitro, using two assay systems. J Enzyme Inhib Med Chem. 2008, 23(2), 198-205.
14. Guogang Tu, Shaohua Li, Huiming Huang, Gang Li, Fang Xiong, Xi Mai, Huawei Zhu, Binhai Kuang, Wen-Fang Xu*. Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold. Bioorg Med Chem. 2008, in proof.
15. GuoGang Tu, Wefang Xu*, Huiming Huang, Shaohua Li. Progress in the development of matrix metalloproteinase inhibitors. Current Medicinal Chemistry, 2008, 15 (14), 1388-1395.
16. Xian-Chao Cheng, Qiang Wang, Hao Fang and Wen-Fang Xu*. Advances in assays of matrix metalloproteinases (MMPs) and their inhibitors. J Enzyme Inhib Med Chem. 2008, 23(2), 154-167.
17. Jianzhi, Gong; Wenfang Xu*; Jie Zhang. Structure and functions of influenza virus neuraminidase. Current. Med. Chem, 2007, 14(1), 113-122.
18. Yepeng Luan; Wenfang Xu*. The structure and main functions of aminopeptidase N. Current. Med. Chem, 2007, 14(6), 639-647.
19. Yu Liu; Jie Zhang; Wenfang Xu*. Recent Progress in Rational Drug Design of Neuraminidase Inhibitors. Current. Med. Chem, 2007, 14(27), 2872-2891.
20. Zhang Jie; Wang Qiang; Fang Hao; Xu Wenfang*; Liu Ailin; Du Guanhua. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors. Bioorg Med Chem, 2007, 15(7), 2749-2758.
21. Qianbin Li, Hao Fang, Wenfang Xu*. Novel 3-galloylamido-N'-substituted-2,6- piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors. Bioorg Med Chem Lett. 2007, 17(10): 2935-2938.
22. Yanling Li , Hao Fang , Wenfang Xu*. Recent advance in the research of flavonoids as anticancer agents. Mini Rev Med Chem. 2007, 7 (7): 663-678.
23. Li Zhang, Jie Zhang, Hao Fang, Qiang Wang and Wenfang Xu* Design Synthesis and Preliminary Evaluation of New Cinnamoyl Pyrrolidine Derivatives as Potent Gelatinase inhibitors. Bioorg Med Chem, 2006,14, 8286-8294.
24. Yepeng Luan; Wenfang Xu*. The function of the selective inhibitors of cyclooxygenase 2. Mini Rev Med Chem. 2006, 6(12):1375-1381.
25. Qu XJ, Yuan YX, Xu WF*, Chen MH, Cui SX, Meng H, Li Y, Makuuchi M, Nakata M, Tang W. Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity. Anticancer Res. 2006, 26(5A): 3573-3578.
26. Jie Zhang, Wenfang Xu*. Recent Advances in Anti-Influenza Agents with Neuraminidase as Target. Mini Review in Med Chem. 2006, 6, 109-120.
27. Xun Li, Kanghui Yang, Wenfang Xu*. Recent advances in the research of quinoxalinone derivatives. Drugs of Future. 2006, 31(10), 979-989.
28. Xian-Chao Cheng, Wenfang XU*. Advances in antidiabetic agents targeting proxisome proliferators activated receptors (PPARS). Drugs of the Future, 2006, 31(10), 875-891.
29. Xun Li, Wenfang Xu*. Recent Patent Therapeutic Agents for Cancer. Recent Patents on Anti-Cancer Drug Discovery, 2006, 1(2), 255-284.
30. Xun Li, Yalin Li, Wenfang Xu* Design, synthesis and evaluation of novel galloyl pyrrolidine derivatives as potential anti-tumor agents. Bioorg Med Chem, 2006, 14(5), 1287-1293.
31. N Zhang, Qi N Ping, Gui H Huang, Xiu Z Han, Yan N cheng and Wen F. Xu*.Tansport Characteristics of Wheat Germ Agglutinin-Modified Insulin-liposomes and Solid Lipid Nanoparticles in a perfused Rat Intestinal Model. Journal of Nanoscience and Nanotechnology, 2006, 6, 1-8.
最新內(nèi)容
鄂ICP備19013881號(hào)-1
